Highest Priced Home Sold in London This Year at 228 Billion KRW
Indian Vaccine Manufacturer SII CEO Purchases Property

The biggest player in this year's London housing market was Adar Poonawalla (42), CEO of the Indian vaccine manufacturer Serum Institute of India (SII).


The British daily The Times reported on the 12th (local time) that Serum Life Sciences, SII's UK subsidiary, purchased a five-story house near Hyde Park for ?138 million (approximately 228 billion KRW). This is the highest price for a house sold in London this year and the second highest ever.


The most expensive house in London is 2-8a Rutland Gate, which was sold in January 2020 by the estate company of former Saudi Crown Prince Sultan bin Abdulaziz for ?210 million (approximately 346.8 billion KRW).


Adar Poonawalla, CEO of Serum Institute of India (SII), a vaccine manufacturer. <br>[Photo by X]

Adar Poonawalla, CEO of Serum Institute of India (SII), a vaccine manufacturer.
[Photo by X]

View original image

The house Adar bought this time, called "Aberconway House," is located in Mayfair, one of London's most prestigious neighborhoods. The living space measures 2,137㎡. It is well known that the daughter of the late Jan Kulczyk, Poland's richest man, purchased it three years ago for ?57 million.


SII is a manufacturer of vaccines for diseases such as polio and diphtheria, and during the COVID-19 pandemic, it was responsible for nearly half of AstraZeneca (AZ) vaccine production.


According to The Times of India, the estimated wealth of the Poonawalla family is $15 billion (approximately 19.7835 trillion KRW), ranking sixth in India. Since 2021, Adar has been renting this house for over ?50,000 (approximately 82.7 million KRW) per week.


Abbeconway House. [Image source=Wikipedia]

Abbeconway House. [Image source=Wikipedia]

View original image

However, an SII official stated that the Poonawalla family does not plan to fully relocate to the UK. The house will serve as a base for the company and family when they are in the UK.



Meanwhile, Adar earned the nickname "Vaccine Prince" after succeeding Cyrus Poonawalla, known as the "Vaccine King," as SII CEO in 2011. He currently serves as chairman of the Poonawalla Group, including SII.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing